What is the recommended dose of ofloxacin (fluoroquinolone antibiotic) for a 14-year-old girl weighing 44 kg with confirmed typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ofloxacin Dosage for Typhoid Fever in a 14-year-old Girl Weighing 44 kg

The recommended dose of ofloxacin for a 14-year-old girl weighing 44 kg with confirmed typhoid fever is 7.5 mg/kg every 12 hours orally (330 mg per dose, maximum 400 mg/dose) for 7-10 days. 1, 2

Dosage Calculation

  • Weight: 44 kg
  • Recommended pediatric dose: 7.5 mg/kg every 12 hours 2
  • Calculation: 44 kg × 7.5 mg/kg = 330 mg per dose
  • Maximum dose: 400 mg per dose 2
  • Frequency: Every 12 hours
  • Duration: 7-10 days 2

Evidence-Based Rationale

The Centers for Disease Control and Prevention (CDC) specifically recommends ofloxacin at 7.5 mg/kg every 12 hours orally (maximum 400 mg/dose) for children with typhoid fever 2. This patient falls below the 45 kg threshold that would qualify her for adult dosing, so the weight-based pediatric dosing is appropriate.

Special Considerations

  1. Safety in Pediatric Population:

    • While fluoroquinolones like ofloxacin have concerns about effects on bone and cartilage growth in children, their use is justified in typhoid fever where benefits outweigh risks 1
    • The patient at 14 years old is approaching skeletal maturity, which reduces these concerns
  2. Efficacy:

    • Ofloxacin has demonstrated excellent efficacy against typhoid fever, including multidrug-resistant strains 3
    • Studies show significantly faster fever clearance and bacterial eradication with ofloxacin compared to alternatives like co-trimoxazole 3
  3. Duration of Treatment:

    • The WHO recommends 7-10 days of treatment for typhoid fever 2
    • Shorter courses (3-5 days) have been studied in adults but are not recommended for pediatric patients without specialist consultation 4, 5

Administration Guidelines

  • Administer orally twice daily
  • Can be taken with or without food (though taking with food may reduce gastrointestinal side effects)
  • Complete the full course of antibiotics even if symptoms improve before completion

Monitoring

  • Monitor for clinical improvement (fever resolution typically within 3-5 days)
  • Watch for potential adverse effects:
    • Gastrointestinal: nausea, diarrhea
    • Neurological: dizziness, headache
    • Dermatological: rash, photosensitivity

Important Caveats

  • Ofloxacin suspension is not commercially available in the United States; tablets will need to be used 2
  • If the patient cannot swallow tablets, consultation with a pharmacist for appropriate administration options is necessary
  • If the patient has renal impairment, dose adjustment would be required
  • Avoid concurrent administration with antacids, sucralfate, or products containing divalent or trivalent cations (calcium, iron, zinc) as they can reduce absorption

This recommendation balances the need for effective treatment of typhoid fever with appropriate consideration of the patient's age and weight, following established guidelines for pediatric dosing of ofloxacin.

References

Guideline

Ofloxacin Guideline Summary

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ofloxacin versus co-trimoxazole in the treatment of typhoid fever in children.

Acta paediatrica Japonica : Overseas edition, 1997

Research

Short course of ofloxacin for treatment of multidrug-resistant typhoid.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995

Research

Short courses of ofloxacin for the treatment of enteric fever.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.